The Fourth Trimester: Pregnancy as a Predictor of Cardiovascular Disease

Pregnancy identifies women who may be at a greater risk of cardiovascular disease (CVD), based on the development of adverse pregnancy outcomes (APOs), and may identify women who may benefit from atherosclerotic CVD (ASCVD) risk reduction efforts. APOs are common and although they are separate diagn...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Pensée Wu, Ki Park, Martha Gulati
Formato:	article
Lenguaje:	EN
Publicado:	Radcliffe Medical Media 2021
Materias:	Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/a3a3c9f0b1fa4515a5d96dc87c039810
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:a3a3c9f0b1fa4515a5d96dc87c039810
record_format	dspace
spelling	oai:doaj.org-article:a3a3c9f0b1fa4515a5d96dc87c0398102021-12-04T16:04:56ZThe Fourth Trimester: Pregnancy as a Predictor of Cardiovascular Disease10.15420/ecr.2021.181758-37641758-3756https://doaj.org/article/a3a3c9f0b1fa4515a5d96dc87c0398102021-09-01T00:00:00Zhttps://www.ecrjournal.com/articleindex/ecr.2021.18https://doaj.org/toc/1758-3756https://doaj.org/toc/1758-3764Pregnancy identifies women who may be at a greater risk of cardiovascular disease (CVD), based on the development of adverse pregnancy outcomes (APOs), and may identify women who may benefit from atherosclerotic CVD (ASCVD) risk reduction efforts. APOs are common and although they are separate diagnoses, all these disorders seem to share an underlying pathogenesis. What is not clear is whether the APO itself initiates a pathway that results in CVD or whether the APO uncovers a woman’s predisposition to CVD. Regardless, APOs have immediate risks to maternal and foetal health, in addition to longer-term CVD consequences. CVD risk assessment and stratification in women remains complex and, historically, has underestimated risk, especially in young women. Further research is needed into the role of ASCVD risk assessment and the effect of aggressive ASCVD risk modification on CVD outcomes in women with a history of APOs.Pensée WuKi ParkMartha GulatiRadcliffe Medical MediaarticleDiseases of the circulatory (Cardiovascular) systemRC666-701ENEuropean Cardiology Review , Vol 16, Iss , Pp - (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Diseases of the circulatory (Cardiovascular) system RC666-701
spellingShingle	Diseases of the circulatory (Cardiovascular) system RC666-701 Pensée Wu Ki Park Martha Gulati The Fourth Trimester: Pregnancy as a Predictor of Cardiovascular Disease
description	Pregnancy identifies women who may be at a greater risk of cardiovascular disease (CVD), based on the development of adverse pregnancy outcomes (APOs), and may identify women who may benefit from atherosclerotic CVD (ASCVD) risk reduction efforts. APOs are common and although they are separate diagnoses, all these disorders seem to share an underlying pathogenesis. What is not clear is whether the APO itself initiates a pathway that results in CVD or whether the APO uncovers a woman’s predisposition to CVD. Regardless, APOs have immediate risks to maternal and foetal health, in addition to longer-term CVD consequences. CVD risk assessment and stratification in women remains complex and, historically, has underestimated risk, especially in young women. Further research is needed into the role of ASCVD risk assessment and the effect of aggressive ASCVD risk modification on CVD outcomes in women with a history of APOs.
format	article
author	Pensée Wu Ki Park Martha Gulati
author_facet	Pensée Wu Ki Park Martha Gulati
author_sort	Pensée Wu
title	The Fourth Trimester: Pregnancy as a Predictor of Cardiovascular Disease
title_short	The Fourth Trimester: Pregnancy as a Predictor of Cardiovascular Disease
title_full	The Fourth Trimester: Pregnancy as a Predictor of Cardiovascular Disease
title_fullStr	The Fourth Trimester: Pregnancy as a Predictor of Cardiovascular Disease
title_full_unstemmed	The Fourth Trimester: Pregnancy as a Predictor of Cardiovascular Disease
title_sort	fourth trimester: pregnancy as a predictor of cardiovascular disease
publisher	Radcliffe Medical Media
publishDate	2021
url	https://doaj.org/article/a3a3c9f0b1fa4515a5d96dc87c039810
work_keys_str_mv	AT penseewu thefourthtrimesterpregnancyasapredictorofcardiovasculardisease AT kipark thefourthtrimesterpregnancyasapredictorofcardiovasculardisease AT marthagulati thefourthtrimesterpregnancyasapredictorofcardiovasculardisease AT penseewu fourthtrimesterpregnancyasapredictorofcardiovasculardisease AT kipark fourthtrimesterpregnancyasapredictorofcardiovasculardisease AT marthagulati fourthtrimesterpregnancyasapredictorofcardiovasculardisease
_version_	1718372690776031232

The Fourth Trimester: Pregnancy as a Predictor of Cardiovascular Disease

Ejemplares similares